Highbridge Capital Management’s Baird Medical Investment Holdings BDMD Stock Holding History

Highbridge Capital Management’s Portfolio BDMD Stock Details BDMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-125,000	Closed	-$230K	–	464
2026 Q1	$230K	Hold	125,000	–	–	0.01%	179
2025 Q4	$170K	Hold	125,000	–	–	0.01%	162
2025 Q3	$265K	Hold	125,000	–	–	0.01%	131
2025 Q2	$458K	Hold	125,000	–	–	0.02%	126
2025 Q1	$651K	Buy	125,000 +12,500	+11%	+$74.9K	0.03%	95
2024 Q4	$855K	Buy	+112,500	New	+$311K	0.03%	129

Other funds holding BDMD

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Highbridge Capital Management's BDMD Position: Q2 2026 in Review

Highbridge Capital Management sold out of Baird Medical Investment Holdings (BDMD) in Q2 2026, closing a stake of 125,000 shares — an estimated $230K sold.

Highbridge Capital Management first reported a position in BDMD in Q4 2024 and held it in 6 quarters. The position peaked at $855K in Q4 2024. 10 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.

Highbridge Capital Management reported no remaining Baird Medical Investment Holdings position as of Q2 2026 after selling out during the quarter.
Highbridge Capital Management sold 125,000 Baird Medical Investment Holdings shares in Q2 2026, an estimated $230K.
Highbridge Capital Management first reported a position in Baird Medical Investment Holdings in Q4 2024 and held it in 6 quarters.
Highbridge Capital Management's Baird Medical Investment Holdings position peaked at $855K in Q4 2024.
10 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.

Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.